Investigation of germline PTEN, p53, p16INK4A/p14ARF, and CDK4 alterations in familial glioma
- 25 April 2000
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 92 (2) , 136-141
- https://doi.org/10.1002/(sici)1096-8628(20000515)92:2<136::aid-ajmg11>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- No evidence for germlinePTEN mutations in families with breast and brain tumoursInternational Journal of Cancer, 1999
- Multiple Primary Cancers in Families With Li-Fraumeni SyndromeJNCI Journal of the National Cancer Institute, 1998
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proceedings of the National Academy of Sciences, 1996
- Incidence of germ‐line p53 mutations in patients with gliomasInternational Journal of Cancer, 1995
- Cell-cycle regulators and cancerTrends in Genetics, 1995
- The Molecular Basis of Turcot's SyndromeNew England Journal of Medicine, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A familial syndrome with cutaneous malignant melanoma and cerebral astrocytomaNeurology, 1993
- TP53 Gene Mutations and 17p Deletions in Human AstrocytomasGenes, Chromosomes and Cancer, 1991